by Hilma Biocare
Pre-filled semaglutide pen. Convenient auto-injector for research use.
In stock
Pay with Bitcoin or USDT (TRC-20) on this site, or contact a representative for a card or bank payment link. Free EU shipping over €250.
Batch certificate of analysis available on request via Telegram or the contact form.
Semaglutide in a pre-filled auto-injector pen — the same delivery format as commercial Ozempic and Wegovy, designed for subcutaneous administration with dose-dial precision. The pen format eliminates reconstitution variables and enables accurate microdose escalation protocols (the clinical standard starts at 0.25 mg weekly and escalates over 16 weeks to 2.4 mg). Each pen contains multi-dose capacity with integrated needle compatibility.
The active compound — 94% homologous to human GLP-1 — provides 7-day receptor occupancy per injection. Ideal for longitudinal metabolic research, obesity intervention models, and comparative GLP-1 receptor agonist studies. Cold-chain maintained through delivery.
Janoshik-verified 99.0% biological purity. For research use only.
Weight Loss & GLP-1
The top 10 most-researched peptides of 2025 ranked by published study volume, mechanistic depth, and research versatility. Covering BPC-157, TB-500, semaglutide, ipamorelin, SS-31, retatrutide, PT-141, CJC-1295, tirzepatide, and NAD+ precursor peptides with their current research status.
6 min read
Peptides & Recovery
Semaglutide-based metabolic research protocols use diet-induced obesity (DIO) rodent models to study GLP-1R-mediated weight loss, glycemic improvement, and lipid remodeling. Guide to the semaglutide DIO research stack — compound selection, protocol design, dose escalation, and endpoints.
4 min read
Peptides & Recovery
Semaglutide is a complex acylated GLP-1 analog requiring HPLC-MS identity verification and high purity COA for legitimate research use. Guide for European researchers on semaglutide quality requirements, EU supply advantages, and what distinguishes research-grade semaglutide from substandard supply.
3 min read
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Must be handled by qualified professionals in a controlled laboratory setting. JuicedPharma makes no therapeutic or medical claims about this compound.
Hilma Biocare
GLP-1 receptor agonist. The active compound in Ozempic/Wegovy research.
99.0%· Janoshik
Pharmacom Labs
Pharmacom T3 liothyronine. 50mcg double-strength tablets.
99%+· Pharmacom
Pharmacom Labs
Sibutramine 15mg double-strength tablets. Central appetite research.
99%+· Pharmacom
ZPHC
Semaglutide 5mg kit (5×1mg) by ZPHC. GLP-1 receptor agonist.
99%+· ZPHC
Resellers, laboratories and publishers: apply for partner pricing, volume terms and a dedicated representative.
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Products sold by JuicedPharma are not medicines. By ordering you confirm you are a qualified person buying for research in compliance with applicable regulations. Full disclaimer